OPRA:NASDAQOpera Limited Analysis

Opera Limited trades at $17.16, well below its DCF‑derived fair value of $34.75, indicating a sizable upside. The stock’s trailing P/E of 14.4 is comfortably under the industry average of 19.0, and the forward P/E of 9.8 underscores expected earnings acceleration. Revenue is growing at a robust 21.5% YoY with guidance for FY‑2026 revenue of $720‑$735 million, while operating margins remain healthy at 16.3% and free cash flow exceeds $90 million, supporting the 4.56% dividend and a payout ratio of 67%. Technicals show price above the 20‑day, 50‑day and 200‑day SMAs, a bullish MACD crossover and an RSI of 68, suggesting short‑term momentum but also a near‑overbought condition. Volume is increasing, yet volatility is high at nearly 40% over the past 30 days and beta exceeds 1.5, flagging price swings. Recent material news highlights a fresh revenue outlook and a prospective $160 million CELO token allocation, which could deepen Web3 advertising revenues. Overall, the combination of undervaluation, solid fundamentals, dividend yield and growth catalysts makes OPRA attractive for investors with a longer horizon, while short‑term caution is warranted due to elevated momentum metrics.